Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 210

Unconstrained growth found in fresh places

Many investors appreciate the extreme concentration in the Australian stock market. Only 20 stocks account for about 60% of the total value of the market, and within those largest 20 stocks, there is a heavy weight to just a few sectors, especially banks and resources.

More subtly, there is also a heavy weighting in a relatively homogenous group of stocks with similar investment attributes.

Big caps dominate

Consider the following 12 stocks in the ASX 20 Index:

  • The four big banks (CBA, Westpac, NAB and ANZ)
  • Telstra
  • Wesfarmers
  • Woolworths
  • Transurban
  • Scentre
  • Suncorp
  • IAG
  • AMP

All are commonly considered ‘blue chips’ and are well owned by Australian super funds and other investors. They account for approximately 27% of the total value of the All Ordinaries Index.

They all have solid core businesses with large market shares in relatively consolidated, mature and domestically-constrained industries. They generate strong and consistent cash flows but have limited opportunities to reinvest those cash flows back and so are left simply to distribute them to shareholders.

Strong dividend yields but little else

Reflecting as much, their investment proposition is generally dependable and attractive dividend yields but little earnings growth.

Despite this, these stocks should not be dismissed. At the right price, their typically fully franked yields are appealing. And, at times, they can offer some interesting growth prospects. For example, the big four banks should grow to the extent that the credit cycle allows. Alas, that is currently very little. Indeed, almost all of them rely on economic or industry conditions for their growth and struggle to achieve any if conditions are not supportive.

But it is not just economic conditions that can constrain earnings growth for these blue chips. Many are also facing a rise in competition. For example, the banks’ more profitable niches are facing competition from financial technology, or 'fintech'; Telstra faces new entrants and new telecommunications networks (TPG Telecom in mobile and NBN resellers in broadband); and Scentre faces online competition pulling retail spend from its shopping centres.

There is perhaps some circularity. When the pie is not growing, growth can only come from taking it from a competitor. Taking market share entails competitive attack and response, most commonly through lower prices that reduce revenues or margins, both of which act to reduce the industry’s profit pool.

For example, last decade the supermarket industry enjoyed benign competition, dominated by Woolworths, and this supported decent earnings growth. Since then, competition has intensified, with a rejuvenated Coles and the expansion of Aldi and Costco. All players have come to ‘invest’ in lower prices and a better service offering, and their investment has pressured the top and bottom-line growth for the industry. With lower barriers to entry, and the possibility of new entrants such as Amazon, the constraint on growth arising from the competition is unlikely to abate.

Diversification has become one investment type

The upshot is that some investors who thought they were diversifying by buying a selection of blue chips have actually concentrated their portfolios into a particular investment style, one characterised as low-growth yield plays.

For genuine diversification, investors should look to companies offering the opposite, such as:

  • offshore markets in which to expand
  • fragmented industry structures
  • differentiated customer offerings enabling market share gains
  • structurally growing markets and
  • opportunities to reinvest cash flows back into the business for growth.

We typically look for companies with ‘exportable competitive advantages’, being those with innovation, brands or products that travel well offshore.

Examples include:


  • Proving that big isn’t always boring the high-growth CSL is a blue chip that is actually the sixth largest stock on the ASX. The company is a low-cost manufacturer of plasma-derived medicines, for which global patient demand is in strong growth. CSL is investing over US$600 million annually in R&D to develop new and improved biomedicines, which allows it to gain a revenue advantage over competitors in respect of each litre of plasma collected. The company continues to leverage this competitive advantage to profitably take market share and expand internationally, including most recently into the large Chinese market.

  • Aristocrat, best known as a slot manufacturer, is spending over $250 million annually on the design and development of new and improved games. Successes like ‘Lightening Link’ allow the company to take market share in the 90 countries it sells into, with the most important being the large US market. The company also leverages its gaming innovation into its nascent online ‘social’ casino-style games business, for which it now has over 1.4 million daily users around the world and counting.


  • BWX owns the Sukin brand, an Australian brand of natural skincare creams that has essentially found its own spot in the ‘masstige’ market. BWX has a strong presence in Australia, but more importantly for its long-term growth prospects, the company is expanding into various offshore markets. It is exporting Sukin products into the UK, where it has just recently started selling through Boots, the UK’s largest pharmacy chain, as well as into Canada, China and elsewhere.

  • Treasury Wine Estates owns luxury and ‘masstige’ wine labels such as Penfolds and Wynns that are increasingly in demand in offshore markets, including most importantly in the high growth and highly profitable Chinese market.


  • Reliance Worldwide manufactures plumbing products, including the innovative Sharkbite branded push-to-connect plumbing fittings. These fittings are growing in popularity among plumbers worldwide, allowing Reliance to steadily take market share, most importantly in its largest market the US, and to enter and expand into other international markets, with the most promising being in Europe.

  • ARB is a manufacturer of four-wheel drive accessories such as bull bars and canopies. It has a strong brand; it tailors its products to specific vehicle makes and develops innovative new products that it exports to 100 countries worldwide. The exporting of these products enable ARB to steadily grow its businesses in offshore markets.


Julian Beaumont is investment director at BAEP, a boutique partner with Bennelong Funds Management. This article is general information that does not consider the circumstances of any individual.



Leave a Comment:



Inflation remains transitory due to strong long-term trends

Kate Howitt: investing lessons and avoiding the PIPO trade

It’s the large stocks driving fund misery


Most viewed in recent weeks

10 little-known pension traps prove the value of advice

Most people entering retirement do not see a financial adviser, mainly due to cost. It's a major problem because there are small mistakes a retiree can make which are expensive and avoidable if a few tips were known.

Check eligibility for the Commonwealth Seniors Health Card

Eligibility for the Commonwealth Seniors Health Card has no asset test and a relatively high income test. It's worth checking eligibility and the benefits of qualifying to save on the cost of medications.

Hamish Douglass on why the movie hasn’t ended yet

The focus is on Magellan for its investment performance and departure of the CEO, but Douglass says the pandemic, inflation, rising rates and Middle East tensions have not played out. Vindication is always long term.

Start the year right with the 2022 Retiree Checklist

This is our annual checklist of what retirees need to be aware of in 2022. It is a long list of 25 items and not everything will apply to your situation. Run your eye over the benefits and entitlements.

At 98-years-old, Charlie Munger still delivers the one-liners

The Warren Buffett/Charlie Munger partnership is the stuff of legends, but even Charlie admits it is coming to an end ("I'm nearly dead"). He is one of the few people in investing prepared to say what he thinks.

Should I pay off the mortgage or top up my superannuation?

Depending on personal circumstances, it may be time to rethink the bias to paying down housing debt over wealth accumulation in super. Do the sums and ask these four questions to plan for your future.

Latest Updates

Investment strategies

Three ways index investing masks extra risk

There are thousands of different indexes, and they are not all diversified and broadly-based. Watch for concentration risk in sectors and companies, and know the underlying assets in case liquidity is needed.

Investment strategies

Will 2022 be the year for quality companies?

It is easy to feel like an investing genius over the last 10 years, with most asset classes making wonderful gains. But if there's a setback, companies like Reece, ARB, Cochlear, REA Group and CSL will recover best.


2022 outlook: buy a raincoat but don't put it on yet

In the 11th year of a bull market, near the end of the cycle, some type of correction is likely. Underneath is solid, healthy and underpinned by strong earnings growth, but there's less room for mistakes.


Time to give up on gold?

In 2021, the gold price failed to sustain its strong rise since 2018, although it recovered after early losses. But where does gold sit in a world of inflation, rising rates and a competitor like Bitcoin?

Investment strategies

Global leaders reveal surprises of 2021, challenges for 2022

In a sentence or two, global experts across many fields are asked to summarise the biggest surprise of 2021, and enduring challenges into 2022. It's a short and sweet view of the changes we are all facing.


What were the big stockmarket listings in record 2021?

In 2021, sharemarket gains supported record levels of capital raisings and IPOs in Australia. The range of deals listed here shows the maturity of the local market in providing equity capital.


Let 'er rip: how high can debt-to-GDP ratios soar?

Governments and investors have been complacent about the build up of debt, but at some level, a ceiling exists. Are we near yet? Trouble is brewing, especially in the eurozone and emerging countries.



© 2022 Morningstar, Inc. All rights reserved.

The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.

Website Development by Master Publisher.